KRISP Dr. Alain Vandormael

Dr. Alain Vandormael

Post-doctoral researcher fellow. Multi-disciplinary research interests, including sociology, epidemiology, statistics, and demography.

Contact Details:

Email: avandormael@africacentre.ac.za

Telephone: +27 (0) 31 260 3744

Background:

As a social epidemiologist, I am interested in identifying the set of demographic, institutional, and clinic level factors that may limit the efficacy of HIV prevention strategies in the South African context. These factors are likely to be associated with distinct and identifiable risk groups that continue to drive the high levels of new HIV infections within rural communities. I have experience in the statistical analysis of surveillance, longitudinal, and cross-sectional survey data using Stata and R. I have also partnered in academic and government settings; collaborated on multidisciplinary research projects, reports and publications; and acquired experience in the planning and management of research-related projects.

Education:

Ph.D. Sociology University of Minnesota, Twin Cities, Sept. 2014

M.S. Statistics University of Minnesota, Twin Cities, February 2014

M.A. Sociology University of Pretoria, South Africa, May 2005

B.A. Psychology University of Pretoria, South Africa, January 2003

Open access pdf	Publications

	Sexual partnership age pairings and risk of HIV acquisition in rural South Africa. Akulliana A, Bershteyna A, Kleina D, Vandormael A, Barnighausen T, Tanser F, AIDS (2017), :DOI:10.1097/QAD.0000000000001553.
	Incidence rate estimation, periodic testing and the limitations of the mid-point imputation approach. Vandormael A, Dobra A, Barnighausen T, de Oliveira T, Tanser F, International Journal of Epidemiology (2017), :doi.org/10.1093/ije/dyx134.
	CD4+ T-cell count may not be a useful strategy to monitor antiretroviral therapy response in HTLV-1/HIV co-infected patients. Vandormael A, Rego F, Danaviah S, Alcantara L, Boulware D, de Oliveira T, Current HIV Research (2017), :doi: 10.2174/1570162X15666170216114917.
	Social disequilibrium and the risk of HIV acquisition: A multilevel study in rural KwaZulu-Natal Province, South Africa. Tomita A, Vandormael AM, Barnighausen T, de Oliveira T, Tanser F, J Acquir Immune Defic Syndr. (2017), :10.1097/QAI.0000000000001349.
	Pairwise diversity and tMRCA as potential markers for HIV infection recency. Moyo S, Wilkinson E, Vandormael A, Wang R, Weng J, Kotokwe KP, Gaseitsiwe S, Musonda R, Makhema J, Essex M, Engelbrecht S, de Oliveira T, Novitsky V , Medicine (Baltimore) (2017), 96:doi: 10.1097/MD.0000000000006041.
	Analysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in Botswana. Moyo S, Vandormael A, Wilkinson E, Engelbrecht S, Gaseitsiwe S, Kotokwe, KP, Musonda R, Tanser F, Essex M, Novitsky V, de Oliveira T, PLoS One (2016), 11(8):DOI:10.1371/journal.pone.0160649.
	Brief Report: Virologic Monitoring Can Be a Cost-Effective Strategy to Diagnose Treatment Failure on First-Line ART. Vandormael AM, Boulware DR, Tanser FC, Barnighuasen TW, Stott KE, de Oliveira T, J Acquir Immune Defic Syndr. (2016), 71(4):462?466.
	Identifying Recent HIV Infections: From Serological Assays to Genomics. Moyo S, Wilkinson E, Novitsky V, Vandormael A, Gaseitsiwe S, Essex M, Engelbrecht S, de Oliveira T , Viruses (2015), 7:5508-5524; doi:10.3390/v7102887.
	Use of antiretroviral therapy in households and risk of HIV acquisition in rural KwaZulu-Natal, South Africa, 2004-12: a prospective cohort study. Vandormael A, Newell ML, Barnighausen T, Tanser F, Lancet Global Health (2014), 2:e209-215.

KRISP News Section from Bioafrica and SATuRN websitesKRISP News Section from Bioafrica and SATuRN websites

News	News Description and Link
KRISP News Section from Bioafrica and SATuRN websites
KRISP News	KwaZulu-Natal Research and Innovation Sequencing Platform (KRISP) Established KRISP News - 2017-07-12 The Technology Innovation Agency (TIA) and UKZN have signed an agreement for the establishment of KRISP - the KwaZulu-Natal Research and Innovation Sequencing Platform.
IDSE Infectious Diseases	CD4+ Count Not Useful to Assess ART Response in HTLV-1/HIV Coinfection IDSE Infectious Diseases - 2017-03-21 Patients coinfected with human T-cell lymphotropic virus 1 (HTLV-1) and HIV continue to have elevated CD4+ T-cell counts, even though there is no difference in their HIV viral load levels after antiretroviral therapy when compared with patients who just have HIV (Curr HIV Res 2017).
EurekaAlert!	CD4+ T-cell count useful to assess antiretroviral therapy response in HTLV-1/HIV patients? EurekaAlert! - 2017-03-17 News coverage and clinical management implication of our recent HIV/HTLV co-infection manuscript, Current HIV Research, 2017

Dr. Alain Vandormael

KRISP News

KRISP News - 2017-07-12

The Technology Innovation Agency (TIA) and UKZN have signed an agreement for the establishment of KRISP - the KwaZulu-Natal Research and Innovation Sequencing Platform.

IDSE Infectious Diseases

IDSE Infectious Diseases - 2017-03-21

Patients coinfected with human T-cell lymphotropic virus 1 (HTLV-1) and HIV continue to have elevated CD4+ T-cell counts, even though there is no difference in their HIV viral load levels after antiretroviral therapy when compared with patients who just have HIV (Curr HIV Res 2017).

EurekaAlert!

EurekaAlert! - 2017-03-17

News coverage and clinical management implication of our recent HIV/HTLV co-infection manuscript, Current HIV Research, 2017